Thrivent Financial for Lutherans’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $688K | Sell |
|
|||||
|
2025
Q2 | $621K | Sell |
|
|||||
|
2025
Q1 | $799K | Sell |
|
|||||
|
2024
Q4 | $1.08M | Sell |
|
|||||
|
2024
Q3 | $1.45M | Sell |
|
|||||
|
2024
Q2 | $1.27M | Sell |
|
|||||
|
2024
Q1 | $1.42M | Sell |
|
|||||
|
2023
Q4 | $2.06M | Sell |
|
|||||
|
2023
Q3 | $2.94M | Sell |
|
|||||
|
2023
Q2 | $5.07M | Buy |
|
|||||
|
2023
Q1 | $1.4M | Sell |
|
|||||
|
2022
Q4 | $1.08M | Sell |
|
|||||
|
2022
Q3 | $1.11M | Buy |
|
|||||
|
2022
Q2 | $1.28M | Buy |
|
|||||
|
2022
Q1 | $1.08M | Buy |
|
|||||
|
2021
Q4 | $698K | Buy |
|
|||||
|
2021
Q3 | $568K | Sell |
|
|||||
|
2021
Q2 | $604K | Sell |
|
|||||
|
2021
Q1 | $550K | Sell |
|
|||||
|
2020
Q4 | $609K | Sell |
|
|||||
|
2020
Q3 | $568K | Buy |
|
|||||
|
2020
Q2 | $634K | Sell |
|
|||||
|
2020
Q1 | $426K | Buy |
|
|||||
|
2019
Q4 | $526K | Sell |
|
|||||
|
2019
Q3 | $543K | Sell |
|
|||||
|
2019
Q2 | $582K | Buy |
|
|||||
|
2019
Q1 | $540K | Buy |
|
|||||
|
2018
Q4 | $486K | Sell |
|
|||||
|
2018
Q3 | $482K | Buy |
|
|||||
|
2018
Q2 | $376K | Buy |
|
|||||
|
2018
Q1 | $429K | Buy |
|
|||||
|
2017
Q4 | $429K | Buy |
|
|||||
|
2017
Q3 | $391K | Buy |
|
|||||
|
2017
Q2 | $386K | Buy |
|
|||||
|
2017
Q1 | $292K | Buy |
|
|||||
|
2016
Q4 | $358K | Buy |
|
|||||
|
2016
Q3 | $361K | Buy |
|